Intriguingly, the expansion of CD81+ Erys was more evident in the spleens of AML mice than in those of PV, EPO-treated, and PHZ-treated mouse models (Supplemental Figure 4K). This evidence concerns the gene CD81 and acute myeloid leukemia.